At the beginning of 2019, Gerresheimer, an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetics industries with headquarters in Germany decided to invest in a new factory, in TIDZ Skopje 2, signed a land lease agreement and celebrated the topping-out ceremony already in October of the same year.

For Gerresheimer this was the first production site in Southeast Europe. North Macedonia was chosen by Gerresheimer because it offers favourable business conditions with trained personnel, good infrastructure, an attractive cost structure and very good support from the authorities.

The plant, which has started production in 2020, initially comprised 12.500 sqm, but has recently been expanded to 20,000 sqm. The facility includes modern ISO Class 7, 8 and 9 cleanrooms of around 10,000 sqm.

To date, Gerresheimer has invested a high double-digit million euro amount in the facility, where Gerresheimer produces drug delivery systems and other medical devices made of plastics as well as ready-to-fill glass syringes.

In 2024, the plant employed more than 200 skilled people from the Republic of North Macedonia with further recruitment underway, has set up a dual training programme for apprentices and cooperates with the University of Skopje.

With 35 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. The company offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems and medical devices as well as solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, cartridges, ampoules, tablet containers, infusion, dropper and syrup bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. With around 12,000 employees, the company generated revenues of around €2bn in 2023.